Vorinostat Alternatives Compared
| Vorinostat | Targretin (bexarotene) | Clobetasol topical |
|
|---|
| Vorinostat | Targretin (bexarotene) | Clobetasol topical |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Cutaneous T-cell Lymphoma. Vorinostat may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Cutaneous T-cell Lymphoma. Targretin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Anal Itching, Atopic Dermatitis, Eczema, Psoriasis, Cutaneous T-cell Lymphoma, Dermatological Disorders, Dermatitis, Lichen Planopilaris, Lichen Planus, Lichen Sclerosus, Necrobiosis... View more |
Related suggestions Cutaneous T-cell Lymphoma
|
|||||||
| More about Vorinostat | More about Targretin (bexarotene) | More about Clobetasol topical | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Targretin has an average rating of 9.5 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Clobetasol topical has an average rating of 8.2 out of 10 from a total of 165 ratings on Drugs.com. 78% of reviewers reported a positive effect, while 13% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Vorinostat side effects |
View all Targretin side effects |
View all Clobetasol topical side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
Lower cost generic |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Targretin prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
|
||||||||
| Brand Names | ||||||||||
| Zolinza |
N/A |
Clobevate, Clobex, Clodan, Cormax, Cormax Scalp, Dermovate, Embeline, Embeline E, Impeklo, Impoyz, Olux, Olux-E, Temovate, Temovate Emollient, Tovet View more | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
2 hours |
7 hours |
N/A |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 87 drugs are known to interact with Vorinostat:
|
A total of 649 drugs are known to interact with Targretin:
|
A total of 48 drugs are known to interact with Clobetasol topical:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
October 06, 2006 |
December 29, 1999 |
December 27, 1985 |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.